Raymond James Financial Services Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $841K | Buy |
|
|||||
|
2024
Q2 | $498K | Buy |
|
|||||
|
2024
Q1 | $493K | Sell |
|
|||||
|
2023
Q4 | $277K | Sell |
|
|||||
|
2023
Q3 | $234K | Buy |
|
|||||
|
2023
Q2 | $262K | Buy |
|
|||||
|
2023
Q1 | $77.8K | Buy |
|
|||||
|
2022
Q4 | $36.7K | Sell |
|
|||||
|
2022
Q3 | $145K | Buy |
|
|||||
|
2022
Q2 | $124K | Buy |
|
|||||
|
2022
Q1 | $107K | Sell |
|
|||||
|
2021
Q4 | $466K | Buy |
|
|||||
|
2021
Q3 | $237K | Sell |
|
|||||
|
2021
Q2 | $363K | Sell |
|
|||||
|
2021
Q1 | $427K | Buy |
|
|||||
|
2020
Q4 | $515K | Buy |
|
|||||
|
2020
Q3 | $160K | Sell |
|
|||||
|
2020
Q2 | $413K | Buy |
|
|||||
|
2020
Q1 | $77K | Buy |
|